Compounds > cystic fibrosis transmembrane conductance regulator (505-511)
Page last updated: 2024-09-03

cystic fibrosis transmembrane conductance regulator (505-511) and Amyotrophic Lateral Sclerosis

cystic fibrosis transmembrane conductance regulator (505-511) has been researched along with Amyotrophic Lateral Sclerosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cooper-Knock, J; Garrard, K; Lo, C; Martindale, J; Shaw, P; Williams, T1

Other Studies

1 other study(ies) available for cystic fibrosis transmembrane conductance regulator (505-511) and Amyotrophic Lateral Sclerosis

ArticleYear
Concurrent amyotrophic lateral sclerosis and cystic fibrosis supports common pathways of pathogenesis.
    Amyotrophic lateral sclerosis & frontotemporal degeneration, 2013, Volume: 14, Issue:5-6

    Topics: Adult; Amyotrophic Lateral Sclerosis; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; DNA-Binding Proteins; Female; Humans; Mutation; Peptide Fragments; RNA Splicing

2013